These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13359490)

  • 1. Effect of histamine, hog vasopressin, and corticotropin-releasing factor (CRF) on ACTH release in vitro.
    SAFFRAN M; SCHALLY AV
    Proc Soc Exp Biol Med; 1956 Jul; 92(3):636-7. PubMed ID: 13359490
    [No Abstract]   [Full Text] [Related]  

  • 2. ACTH releasing activity in vivo of a CRF preparation and lysine vasopressin.
    GUILLEMIN R; DEAR WE; NICHOLS B; LIPSCOMB HS
    Proc Soc Exp Biol Med; 1959 May; 101(1):107-11. PubMed ID: 13658207
    [No Abstract]   [Full Text] [Related]  

  • 3. ACTH release by in vitro pituitary; effect of pitressin and purified arginine-vasopressin.
    GUILLEMIN R; HEARN WR
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):365-7. PubMed ID: 13254762
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of vasopressin and of a crude CRF preparation on pituitary ACTH-release in posterior-lobectomized rats.
    de Wied D
    Neuroendocrinology; 1968; 3(3):129-35. PubMed ID: 4301554
    [No Abstract]   [Full Text] [Related]  

  • 5. ACTH releasing factor active in the guinea pig.
    SIDEMAN M; SOBEL H
    Proc Soc Exp Biol Med; 1960 Feb; 103():274-7. PubMed ID: 14446415
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACTH releasing action of vasopressin].
    Hiroshige T
    Saishin Igaku; 1971 Apr; 26(4):697-705. PubMed ID: 4329833
    [No Abstract]   [Full Text] [Related]  

  • 7. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1992 Sep; 56(3):419-28. PubMed ID: 1331840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs.
    Knepel W; Homolka L; Vlaskovska M; Nutto D
    Neuroendocrinology; 1984 May; 38(5):344-50. PubMed ID: 6328345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticoliberin activity of rat neurohypophysis is distinct from vasopressin.
    Kárteszi M; Stark E; Rappay G; László FA; Makara GB
    Am J Physiol; 1981 Jun; 240(6):E689-93. PubMed ID: 6264793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro effects of corticosterone, synthetic ovine corticotrophin releasing factor and arginine vasopressin on the release of adrenocorticotrophin by fetal rat pituitary glands.
    Dupouy JP; Chatelain A
    J Endocrinol; 1984 Jun; 101(3):339-44. PubMed ID: 6327872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the corticotrophin-releasing activity of vasopressin, using ACTH secretion by cultured rat adenohypophyseal cells.
    Yasuda N; Greer MA
    Endocrinology; 1976 Apr; 98(4):936-42. PubMed ID: 179790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin.
    Turkelson CM; Thomas CR; Arimura A; Chang D; Chang JK; Shimizu M
    Peptides; 1982; 3(2):111-3. PubMed ID: 6285317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of ACTH and vasopressin in neurohypophysectomized conscious dogs.
    Raff H; Merrill D; Skelton M; Cowley AW
    Am J Physiol; 1985 Aug; 249(2 Pt 2):R281-4. PubMed ID: 2992297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased corticotropin-releasing factor receptor expression and adrenocorticotropic hormone responsiveness in anterior pituitary cells of Wistar-Kyoto rats.
    Hauger RL; Shelat SG; Redei EE
    J Neuroendocrinol; 2002 Feb; 14(2):126-34. PubMed ID: 11849372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of vasopressin (ADH) for the release of corticotropin from the adenohypophysis.
    de WIED
    Acta Neuroveg (Wien); 1961; 23():63-8. PubMed ID: 14006763
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of synthetic ovine corticotropin releasing factor and arginine vasopressin on in vitro ACTH release by the anterior pituitary of rats.
    Murakami K; Hashimoto K; Ota Z
    Neuroendocrinology; 1984 Jul; 39(1):49-53. PubMed ID: 6087183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Production of corticotropin releasing factor free of vasopressin by coutner-current distribution].
    GROS C; PRIVAT DE GARILHE M
    C R Hebd Seances Acad Sci; 1959 Nov; 249():2234-6. PubMed ID: 13829583
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vasopressin and "CRF" in the regulation of ACTH secretion by the anterior and intermediate lobes of the pituitary gland (author's transl)].
    Lutz-Bucher B; Briaud B; Koch B; Schmitt G
    J Physiol (Paris); 1981 Mar; 77(8):939-50. PubMed ID: 6122732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.
    Suda T; Tomori N; Tozawa F; Mouri T; Demura H; Shizume K
    Endocrinology; 1984 Mar; 114(3):851-4. PubMed ID: 6321142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide does not affect corticotropin-releasing factor-, arginine vasopressin- and angiotensin II-induced adrenocorticotropic hormone release in vivo or in vitro.
    Hashimoto K; Hattori T; Suemaru S; Sugawara M; Takao T; Kageyama J; Ota Z
    Regul Pept; 1987 Jan; 17(1):53-60. PubMed ID: 3031746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.